Wealthfront Advisers LLC Acquires New Shares in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Wealthfront Advisers LLC acquired a new stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 22,525 shares of the company’s stock, valued at approximately $263,000. Other large investors have also recently added to or […]
Wealthfront Advisers LLC acquired a new stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 22,525 shares of the company’s stock, valued at approximately $263,000. Other large investors have also recently added to or […]
